Static magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385
about
Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's diseaseThe anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cellsAnalysis of the effect of repeated-pulse transcranial magnetic stimulation at the Guangming point on electroencephalograms.In vitro effect of adenosine on the mRNA expression of Kir 2.1 and Kir 4.1 channels in rat retinal Müller cells at elevated hydrostatic pressure.Comparative evaluation of chitosan, cellulose acetate, and polyethersulfone nanofiber scaffolds for neural differentiation.Cell type- and density-dependent effect of 1 T static magnetic field on cell proliferation.Rational drug discovery design approaches for treating Parkinson's disease.Extremely low-frequency electromagnetic fields: A possible non-invasive therapeutic tool for spinal cord injury rehabilitation.Involvement of Na+/K+ pump in fine modulation of bursting activity of the snail Br neuron by 10 mT static magnetic field.Static magnetic field effect on microcirculation, direct versus baroreflex-mediated approach.Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells.Activation of adenosine A2A receptor up-regulates BDNF expression in rat primary cortical neurons.A static magnetic field attenuates lipopolysaccharide-induced neuro-inflammatory response via IL-6-mediated pathway.Static magnetic fields enhance dental pulp stem cell proliferation by activating the p38 mitogen-activated protein kinase pathway as its putative mechanism.3D additive-manufactured nanocomposite magnetic scaffolds: Effect of the application mode of a time-dependent magnetic field on hMSCs behavior.Static magnetic fields reduce epileptiform activity in anesthetized rat and monkey
P2860
Q26782971-CB79B791-E794-4D04-8557-0D049358E809Q28728011-40862B73-4D2C-432D-AF28-0F778C5C18CBQ34128083-BBAF9F61-8F87-4770-BA3E-0AE5F1552AFBQ36224317-1E7C5A5E-BED4-4D80-8C82-7B3BE244D789Q37375832-29037750-2A9E-4217-8ACE-3C43A31BF74BQ37706560-AB906DF1-7B71-4B8E-868C-A7FA85B85977Q38520864-8B585E12-B3F3-4D2E-9C6A-50423561ECA1Q38892367-E35F1DC0-A3F9-4C2D-9D46-6F066607F37BQ44210797-23BC2201-840E-42BB-B446-934287B099FCQ45366659-E44ABDB9-E8DB-44DD-A03E-7B8DAB791699Q46488331-0C507329-94C7-4D08-9D1A-C27620D7A571Q48986745-BCB310B3-169B-4909-9024-5E0C7CDE537EQ50895004-2F59DDAB-EC27-494C-BEB4-07C1332AB53AQ51149962-0DC837A9-F39D-4194-9C57-D8642180B081Q54949181-C1E2435C-F238-4A0D-B7FC-3B82851EDE26Q58099087-52C9F9DB-FD5A-46E4-9575-BDEB66CEFAD4
P2860
Static magnetic field exposure reproduces cellular effects of the Parkinson's disease drug candidate ZM241385
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Static magnetic field exposure ...... isease drug candidate ZM241385
@ast
Static magnetic field exposure ...... isease drug candidate ZM241385
@en
Static magnetic field exposure ...... isease drug candidate ZM241385
@nl
type
label
Static magnetic field exposure ...... isease drug candidate ZM241385
@ast
Static magnetic field exposure ...... isease drug candidate ZM241385
@en
Static magnetic field exposure ...... isease drug candidate ZM241385
@nl
prefLabel
Static magnetic field exposure ...... isease drug candidate ZM241385
@ast
Static magnetic field exposure ...... isease drug candidate ZM241385
@en
Static magnetic field exposure ...... isease drug candidate ZM241385
@nl
P2093
P2860
P1433
P1476
Static magnetic field exposure ...... isease drug candidate ZM241385
@en
P2093
Barbara Ha
Kevin J Yarema
Pao-Lin Che
Zhiyun Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0013883
P407
P50
P577
2010-11-08T00:00:00Z